mcas and tirzepatide New research highlights the use of #GLP1 receptor agonists (like semaglutide & tirzepatide) in treating mast cell activation syndrome (MCAS). In this case series, patients reported: • Rapid symptom relief (fatigue, brain Can GLP-1 Medications Help MCAS,

Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: a double-blind, placebo-controlled study

Follow recommended dosages, get baseline bloodwork, and work with your healthcare provider to determine what your body actually needs

Reduce your cravings 95% say their appetite is lower since starting Amble

Whilst these medications are not licensed specifically for dyslipidaemia treatment, clinical trials show reductions in total cholesterol, LDL cholesterol, and triglycerides alongside their primary metabolic benefits

GLP-1 agonists produce dramatic weight loss (averaging 15-20% total body weight) primarily through central appetite suppression, eliminating hunger and creating pharmaceutical satiety